Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,682.2
29.2 (1.10%)

 

  • STI Straits Times Index
    2,682.2
    29.2 (1.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,167.5
    794.4 (3.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,316.6
    163.8 (5.20%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,702.0
    395.5 (1.77%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 834.2M
  • Value: 529.8M
  • Rise: 228
  • Fall: 65
  • Unch: 515

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.121+0.006
Rex Intl0.186+0.006
Medtecs Intl0.590+0.090
LionGold0.002-
Yoma Strategic0.320+0.005
Synagie0.197+0.006
MDR0.001-
AnAn Intl0.070+0.006
ThaiBev0.715+0.020
KOP0.069+0.008

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

FISHER & PAYKEL HEALTHCARE CORP FISHER & PAYKEL HEALTHCARE CORPORATION
Updated on 03 Jul 2020 (End of trading day)
Last (AUD): 32.910 Change: +1.140 High: 33.200 Remarks: -
Change (%): +3.59 Low: 32.400
Open 32.590 Yesterday's Close 31.769999999999996
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 693,893 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a 0.47513 Trailing EPS (AUD) e 0.47513 NAV (AUD) b 1.6417
PE a 69.265 Trailing PE f 69.265 Price / NAV b 20.0463
Dividend (AUD) d - Cash In Hand (AUD) g 0.1131 Issued & Paid-up Shares c 574,551,897
Dividend Yield (%) d - Price / Cash In Hand g 290.981 Treasury Shares h 290,103
Beta - 75 Daysi 0.816 R-Squared - 75 Days(%)i 13.79 Market Cap (M) 18,908.503
Beta - 500 Daysi 0.932 R-Squared - 500 Days (%)i 16.54 Enterprise Value (M) 18,900.173
Piotroski F Score 6 Exchange Code FPH Par Value ( NZD ) n.a.
52 Weeks Volatility (%) 31.92 Free Float (%) 99.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jun 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference FISHER & PAYKEL HEALTHCARE CORP ASX 18,908.503 69.265 69.265 20.0463 -
Industry Medical Specialties ASX 2,157.888 85.444 85.760 12.0101 0.587
Local Peer COCHLEAR LTD ASX 13,400.230 48.429 43.820 16.6256 1.421
Local Peer EBOS GROUP ASX 3,346.855 24.305 21.970 2.6051 3.382
Local Peer NANOSONICS LIMITED ASX 2,068.156 152.044 169.410 17.5914 -
Local Peer MCP INCOME OPPORTUNITIES TRUST ASX 488.041 - - -341.8367 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 472.489 455.120 412.294 10.6383 0.555
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 376.419 - - 7.4421 -
Local Peer ATOMO DIAGNOSTICS LIMITED ASX 187.961 - - - -
Local Peer RESAPP HEALTH LIMITED ASX 120.819 - - 25.3968 -
Local Peer CYCLOPHARM LIMITED ASX 112.944 - - 4.8668 0.693
Local Peer SOMNOMED LIMITED ASX 110.897 - - 5.5189 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 104.755 - - 14.6822 -
Local Peer NOVA EYE MEDICAL LIMITED ASX 101.957 - - - -
Other Local Peers SDI LTD (ASX), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), COMPUMEDICS (ASX), RESONANCE HEALTH LTD (ASX), RESPIRI LTD (ASX), OVENTUS MEDICAL LTD (ASX), MICRO-X LTD (ASX), LBT INNOVATIONS LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), OPTISCAN IMAGING (ASX), CARDIEX LTD (ASX), ADHERIUM LIMITED (ASX), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), STERIS PLC (NYSE), HARTA (Bursa), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), AK MEDICAL (HKEx), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), SUPERMX (Bursa), PEIJIA-B (HKEx), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), KDL MEDICAL (HKEx), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), LIFETECH SCI (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CIRC (HKEx), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), PW MEDTECH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UG Healthcare (SGX), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), VINCENT MED (HKEx), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), LKL (Bursa), Biolidics (SGX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), ELECTROCORE INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), LIFE HEALTHCARE (HKEx), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), DIGIRAD CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), Annica (SGX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+3.280
+11.07 %
10 Days -+6.030
+22.43 %
20 Days -+6.850
+26.29 %
Medium Term Return 3 Months -+3.750
+12.86 %
6 Months -+11.700
+55.16 %
1 Year -+17.420
+112.46 %
Long Term Return 2 Years -+18.830
+133.74 %
3 Years 0.135+22.300
+211.45 %
5 Years 0.135+26.570
+421.21 %
Annualised Return Annualised --
+39.12 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 14.000 - 33.200 Change From 1 Year Low +18.910 % Change From 1 Year Low (%) +135.07
Change From 1 Year High -0.290 % Change From 1 Year High (%) -0.87
2 Years Range 11.280 - 33.200 Change From 2 Years Low +21.630 % Change From 2 Years Low (%) +191.76
Change From 2 Years High -0.290 % Change From 2 Years High (%) -0.87
5 Years Range 6.320 - 33.200 Change From 5 Years Low +26.590 % Change From 5 Years Low (%) +420.73
Change From 5 Years High -0.290 % Change From 5 Years High (%) -0.87
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following segments: The New Zealand, North America, Europe, and Asia-Pacific. New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. The North America segment refers to all activities controlled by entities or employees based in the United States of America and Canada, principally sales, distribution and administration activities. The Europe segment includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, principally sales, distribution and administration activities. The Asia-Pacific segment refers to all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, principally sales, distribution and administration activities. The company was founded in 1934 and is headquartered in Auckland, New Zealand.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jul 2020 32.590 33.200 32.400 32.910 693,893 -
01 Jul 2020 32.880 32.880 31.620 31.770 1,022,621 -
30 Jun 2020 32.650 33.170 32.190 32.840 1,054,010 -
29 Jun 2020 31.090 31.780 30.560 31.670 887,821 -
26 Jun 2020 29.140 30.020 28.530 29.630 1,079,723 -
25 Jun 2020 28.660 29.045 28.560 28.850 676,863 -
24 Jun 2020 28.720 28.920 28.280 28.850 655,698 -
23 Jun 2020 27.910 28.790 27.750 28.390 880,848 -
22 Jun 2020 27.030 27.730 26.820 27.480 521,516 -
19 Jun 2020 27.060 27.520 26.650 26.880 1,826,159 -
18 Jun 2020 27.490 27.850 26.760 27.000 1,093,739 -
17 Jun 2020 26.750 28.040 26.750 27.660 1,538,665 -
16 Jun 2020 26.760 26.920 26.150 26.260 1,047,913 -
15 Jun 2020 26.410 26.880 26.110 26.110 536,137 -
12 Jun 2020 26.650 27.000 26.580 26.770 717,577 -
11 Jun 2020 26.450 27.210 26.380 26.910 907,628 -
10 Jun 2020 26.200 26.790 26.090 26.440 724,967 -
09 Jun 2020 27.100 27.750 26.440 26.650 1,160,929 -
05 Jun 2020 26.890 27.190 25.900 26.060 1,051,954 -
04 Jun 2020 27.270 27.520 26.520 26.930 1,404,888 -
03 Jun 2020 27.690 27.800 26.960 27.270 563,311 -
02 Jun 2020 27.500 28.050 27.150 27.760 569,792 -
Summary
Current 2 Weeks
(19 Jun 2020 to 03 Jul 2020)
27.060 33.200 26.650 32.910 9,299,152 -
Previous 2 Weeks
(04 Jun 2020 to 18 Jun 2020)
27.270 33.200 26.520 27.000 10,184,397 -
4 Weeks from
(07 May 2020 to 03 Jun 2020)
27.290 33.200 26.650 27.270 12,657,987 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.